MINERVA MEDICA is a renowned academic journal published by EDIZIONI MINERVA MEDICA, located in Turin, Italy. Established in 1945, it has positioned itself as a significant contributor to the field of medicine, particularly in the miscellaneous medicine category, as evidenced by its Q3 ranking according to the 2023 category quartiles. The journal is indexed under the ISSN 0026-4806 and E-ISSN 1827-1669, ensuring wide accessibility and dissemination of knowledge among medical professionals, researchers, and students alike. With a robust Scopus ranking of #64 out of 636 in General Medicine, placing it in the 90th percentile, MINERVA MEDICA serves as a vital resource for those seeking to stay updated on contemporary medical research and advancements. While not an open-access journal, its commitment to quality and relevance in the medical landscape makes it an essential read for anyone involved in the healthcare sector.

Welcome to the Alexandria Journal of Medicine, a premier open-access publication dedicated to advancing medical knowledge and practice since its inception in 2016. Published by the respected Taylor & Francis Ltd, this journal provides a platform for the dissemination of innovative research in all areas of medicine. With an increasing focus on accessibility, the journal ensures that its valuable content is available to a global audience, fostering collaboration and dialogue among healthcare professionals, researchers, and students alike. The Alexandria Journal of Medicine encourages rigorous peer-reviewed articles that present novel findings, systematic reviews, and insights into clinical practices, making it an essential resource for those at the forefront of medical research. Leveraging a commitment to quality and relevance, this journal aims to impact the ever-evolving landscape of healthcare and contribute to better health outcomes worldwide.

Network Modeling and Analysis in Health Informatics and Bioinformatics, published by SPRINGER WIEN, stands as a vital resource in the interdisciplinary domains of health informatics and bioinformatics. With an ISSN of 2192-6662 and E-ISSN of 2192-6670, this journal aims to facilitate the dissemination of innovative research that intersects network modeling, data analysis, and health applications. The journal competes at a Q3 quartile level across multiple categories including Biomedical Engineering and Health Informatics, showcasing its growing influence within the academic community. As of 2023, it holds impressive Scopus rankings, including a 20th position in Urology, illustrating its significance in the field. Although not an open access publication, the journal is dedicated to providing cutting-edge insights from 2012 to 2024 and is poised to attract researchers, professionals, and students striving to push the boundaries of knowledge in health informatics and bioinformatics. This journal is not just a platform for sharing scholarly articles; it is a catalyst for advancing methodologies that enhance patient care and medical research.

Revista da Associacao Medica Brasileira, with ISSN 0104-4230 and E-ISSN 1806-9282, is a premier open access journal published by the Associacao Medica Brasileira, located in São Paulo, Brazil. Established in 1976, it has transitioned to an open access model since 1997, making significant contributions to the field of medicine by ensuring that research is freely accessible to a global audience. The journal covers a broad spectrum of medical topics, catering to the diverse interests of researchers, healthcare professionals, and students, and holds a commendable position in the Scopus rankings, being placed in the 63rd percentile of general medicine journals, ranked #230 out of 636. With its commitment to disseminating valuable medical knowledge, Revista da Associacao Medica Brasileira has solidified its role as a vital resource for advancing medical research and practice in Brazil and beyond.

Current Genetic Medicine Reports, published by SPRINGERNATURE, is a prominent journal dedicated to advancing the field of genetic medicine. With an emphasis on the latest research and advancements, this journal serves as a critical platform for disseminating high-quality original articles, reviews, and reports that focus on the application of genetic information in various medical disciplines. As an open-access journal, it ensures that valuable findings are freely accessible to a global audience, thereby fostering collaboration and innovation among researchers, healthcare professionals, and students alike. Although the journal does not yet have an established impact factor, its commitment to rigorous peer review and its contributions to the understanding and integration of genetic medicine into clinical practice enhance its scholarly significance. The editorial board is comprised of leading experts, encouraging submissions that tackle contemporary issues in genetic research and its clinical applications. Located in London, England, this journal is poised to be a vital resource for those seeking to stay abreast of the rapid changes in the dynamic field of genetic medicine.

Welcome to the Erciyes Medical Journal, a distinguished publication from the Erciyes University School of Medicine that has been dedicated to advancing the field of medical science since its establishment. This Open Access journal, available in both print (ISSN: 2149-2247) and online (E-ISSN: 2149-2549), offers researchers unparalleled access to cutting-edge research and medical advancements. Following its transition to open access in 2018, the journal aims to democratize knowledge, allowing healthcare professionals, researchers, and students alike to engage with high-quality content that is both accessible and impactful. Although its coverage in databases such as Scopus has been discontinued since 2018, the Erciyes Medical Journal continues to foster scholarly dialogue and innovation in medicine, addressing critical health issues relevant to the global community. As a hub for knowledge exchange, this journal not only publishes original research articles but also encourages the submission of reviews, case studies, and clinical practice articles, thereby facilitating a comprehensive understanding of medical challenges and breakthroughs.

TECHNOLOGY AND HEALTH CARE, published by IOS PRESS, stands as a prominent interdisciplinary journal dedicated to the integration of technology within the healthcare sector. With an ISSN of 0928-7329 and an E-ISSN of 1878-7401, this journal has been a vital resource since its inception in 1993, providing insights and advancements in various categories including bioengineering, biomedical engineering, health informatics, and more. Though it currently holds a Q4 classification in several fields and Q3 in others, it actively contributes to the dialogue surrounding innovative methodologies and practices that enhance healthcare delivery. Researchers, professionals, and students will find the journal invaluable for its diverse range of studies that explore the convergence of technology and health. Its commitment to fostering impactful research continues to reinforce its relevance in the evolving landscape of healthcare technology.

JAMA - Journal of the American Medical Association, published by the American Medical Association, stands as a leading voice in the field of medicine, with an impressive impact factor that reflects its status as a pivotal resource for health professionals. Established in 1883, JAMA has consistently evolved to meet the changing landscape of medical research and practice, converging its insights into the realm of general medicine through to 2024. As a Q1 journal in the Medicine (miscellaneous) category, JAMA ranks notably at #6 out of 636 in Scopus, placing it within the 99th percentile of its field. Although it does not currently offer open access options, JAMA remains a critical platform for disseminating groundbreaking research and clinical studies, facilitating engagement among researchers, healthcare professionals, and students alike. Its commitment to advancing health knowledge makes it an indispensable asset for anyone dedicated to the pursuit of excellence in medical science.

The New England Journal of Medicine (NEJM), published by the Massachusetts Medical Society, stands as a beacon of excellence in the field of medicine. With an impressive impact factor and a prestigious rank of #2 out of 636 in General Medicine, NEJM is recognized in the Q1 category for its significant contributions to medical research and clinical practice since its inception in 1945. The journal is renowned for publishing groundbreaking studies, reviews, and commentaries that influence clinical guidelines and healthcare policies worldwide. While the journal is not open access, it provides pivotal resources that are essential for researchers, healthcare professionals, and students looking to stay abreast of the latest developments in medicine. With a commitment to advancing medical knowledge, NEJM plays a crucial role in bridging the gap between laboratory research and clinical application.

Med, an esteemed journal published by CELL PRESS, stands at the forefront of interdisciplinary medical research, making significant contributions to the field of Medicine since its inception in 2020. With an impressive Q1 ranking in the Medicine (miscellaneous) category and a notable 96th percentile ranking in General Medicine according to Scopus, this journal is dedicated to disseminating high-quality research that advances medical knowledge and practice. Med provides a platform where researchers, professionals, and students can share their findings and insights, fostering a collaborative environment that bridges various aspects of medicine. While offering a comprehensive body of research, Med is committed to promoting open communication within the scientific community, ensuring that valuable information is accessible to those who seek to enhance their understanding and application of medical science. With a strong presence in the United States and a global readership, Med is poised to influence the future of healthcare significantly.